Back to Search
BEATRICE EISENBERG, RPH, PHARMD
RPH, PHARMD
Pharmacist
NPI: 1720153554Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PH00014568(WA)
Research & Publications (20)
Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.
PMID 19116881·Nutr Cancer·2009
8-other
Ions and inhibitors in the binding site of HIV protease: comparison of Monte Carlo simulations and the linearized Poisson-Boltzmann theory.
PMID 19217848·Biophys J·2009
4-observational
Ionic selectivity in L-type calcium channels by electrostatics and hard-core repulsion.
PMID 19398776·J Gen Physiol·2009
7-preclinical
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
PMID 19585585·Genes Chromosomes Cancer·2009
8-other
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
PMID 18942073·J Surg Oncol·2009
3-trial
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.
PMID 19671739·Mol Cancer Ther·2009
3-trial
Targeted therapies: GIST adjuvant therapy-some answers and more questions.
PMID 19644534·Nat Rev Clin Oncol·2009
8-other
The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.
PMID 18818517·Cell Cycle·2008
6-review
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.
PMID 18235121·J Clin Oncol·2008
3-trial
The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
PMID 18259941·Cancer Invest·2008
8-other
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
PMID 18550829·Proc Natl Acad Sci U S A·2008
8-other
Behavioural improvements with thalamic stimulation after severe traumatic brain injury.
PMID 17671503·Nature·2007
5-case
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 17158528·J Clin Oncol·2007
8-other
Combined effect of pore radius and protein dielectric coefficient on the selectivity of a calcium channel.
PMID 17501467·Phys Rev Lett·2007
8-other
Steric selectivity in Na channels arising from protein polarization and mobile side chains.
PMID 17526571·Biophys J·2007
8-other
A biological porin engineered into a molecular, nanofluidic diode.
PMID 17691852·Nano Lett·2007
8-other
Combined-modality strategy for gastrointestinal stromal tumors.
PMID 17178293·Semin Oncol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5303 PACIFIC HWY E
FIFE, WA 98424 - Phone
- (253) 922-0222
Quick Facts
- NPI
- 1720153554
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile